Governments seek buyer as Quebec COVID-19 vaccine manufacturer Medicago set to close
Global News
Pierre Fitzgibbon said the province has had preliminary talks with potential buyers in the pharmaceutical sector to keep Medicago's expertise and skilled workforce in Quebec.
The Quebec government says it’s looking to find a buyer for Medicago Inc., the Quebec-based COVID-19 vaccine manufacturer that will be shut down by parent company Mitsubishi Chemical.
Quebec Economy Minister Pierre Fitzgibbon said Friday the province has had preliminary talks with potential buyers in the pharmaceutical sector to keep Medicago’s expertise and skilled workforce in Quebec. He said both the Quebec and federal governments would be willing to put in money to secure a deal.
“We can’t operate it ourselves; the government will not be the main shareholder,” Fitzgibbon said. “But if there is a pharmaceutical company that considers it’s worth continuing, we’re ready to help.”
Mitsubishi Chemical said Thursday it would stop marketing the Medicago-produced Covifenz vaccine, which is plant-based and was approved by Health Canada one year ago for adults aged 18 to 64.
The Japanese chemical company said it had been preparing to commercially produce the Covifenz vaccine but decided against doing so because of the “significant changes” in the COVID-19 vaccine environment. The company said it would dissolve Medicago because it is no longer “viable” to continue marketing its products.
“In light of significant changes to the COVID-19 vaccine landscape since the approval of Covifenz, and after a comprehensive review of the current global demand and market environment for COVID-19 vaccines and Medicago’s challenges in transitioning to commercial-scale production, the (company) has determined that it will not pursue the commercialization of Covifenz,” Mitsubishi Chemical said in a statement.
Following the announcement, Medicago issued a statement thanking its employees. “The Medicago team has pushed scientific boundaries and we know that they will continue to make incredible contributions to innovation and biopharmaceutical’s sector.”
Canada invested $173 million in Medicago in 2020 to support development of the Covifenz vaccine and help Medicago expand its production facility in Quebec City.
Canada has a chance to make history with another gold medal game, while the men have their eyes on making it to another gold medal game on Sunday, potentially meeting the U.S.
Atlantic Canada’s population boom has ended, with each of the four provinces losing residents at the end of 2025.
A review into controversial dog testing at a London, Ont., hospital that irked Premier Doug Ford found it was ethical with no evidence of 'secrecy.'
Calls to the Canadian Human Trafficking Hotline hit more than 5,900 calls nationwide in 2025, a 14 per cent increase from 5,100 calls in 2024, the organization said.
Inspired by his 2019 crash, Painworth co-founder Mike Zouhri says the company aims to make injury claims more affordable and accessible.
LeBlanc said Ottawa and their Mexican counterparts are in agreement that a North American deal involving all three countries is the best way forward.
A recent ruling from the Quebec human rights tribunal has put Station10 hair salon at the centre of a larger legal battle and social debate.
The news comes a year and half after former health minister Adrian Dix announced the much-needed replacement, saying then it was long overdue.
Democrats are demanding Ambassador Bridge owner Matthew Moroun provide documentation of a reported meeting held with U.S. Commerce Secretary Howard Lutnick before Trump's threat.
From trade tensions to a shrinking workforce and existing inflation, several factors are leading to provinces posting sometimes record-breaking budgets.
The newly launched consumer rebates for electric vehicles aim to help make the purchase more affordable — but how does the cost of powering one compare with a gas vehicle?
The Kamloops institution operated between 1890 and 1969, when Ottawa took control from the Catholic Church and ran it as a day school until it closed in 1978.
The first category that’s being added is for researchers and senior managers with Canadian work experience to help drive research in Canada.